82 related articles for article (PubMed ID: 8859002)
1. Characterization of the prostanoid TP receptor population in human nonpregnant myometrium.
Senchyna M; Crankshaw DJ
J Pharmacol Exp Ther; 1996 Oct; 279(1):262-70. PubMed ID: 8859002
[TBL] [Abstract][Full Text] [Related]
2. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
[TBL] [Abstract][Full Text] [Related]
3. Operational correlates of prostanoid TP receptor expression in human non-pregnant myometrium are unaffected by excision site or menstrual cycle status of the donor.
Senchyna M; Crankshaw DJ
Br J Pharmacol; 1999 Dec; 128(7):1524-8. PubMed ID: 10602332
[TBL] [Abstract][Full Text] [Related]
4. Effects of the isoprostane, 8-epi-prostaglandin F2 alpha, on the contractility of the human myometrium in vitro.
Crankshaw D
Eur J Pharmacol; 1995 Oct; 285(2):151-8. PubMed ID: 8566133
[TBL] [Abstract][Full Text] [Related]
5. Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets.
Folger WH; Halushka PV; Wilcox CS; Guzman NJ
Eur J Pharmacol; 1992 Sep; 227(1):71-8. PubMed ID: 1426024
[TBL] [Abstract][Full Text] [Related]
6. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane receptors in human kidney tissues.
Brown GP; Venuto RC
Prostaglandins Other Lipid Mediat; 1999 Jun; 57(4):179-88. PubMed ID: 10402213
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a rat kidney thromboxane A2 receptor: high affinity for the agonist ligand I-BOP.
D'Angelo DD; Terasawa T; Carlisle SJ; Dorn GW; Lynch KR
Prostaglandins; 1996 Oct; 52(4):303-16. PubMed ID: 8936585
[TBL] [Abstract][Full Text] [Related]
9. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
10. Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.
Dorn GW
J Clin Invest; 1989 Dec; 84(6):1883-91. PubMed ID: 2531760
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the vascular thromboxane A2/prostaglandin endoperoxide receptor in rabbit aorta. Regulation by dexamethasone.
Sessa WC; Halushka PV; Okwu A; Nasjletti A
Circ Res; 1990 Dec; 67(6):1562-9. PubMed ID: 2147131
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes.
Crankshaw DJ; Gaspar V
J Reprod Fertil; 1995 Jan; 103(1):55-61. PubMed ID: 7535849
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological evidence for thromboxane receptor heterogeneity--implications for the eye.
Krauss AH; Woodward DF; Burk RM; Gac TS; Gibson LL; Protzman CE; Abbass F; Marshall K; Senior J
J Ocul Pharmacol Ther; 1997 Aug; 13(4):303-12. PubMed ID: 9261766
[TBL] [Abstract][Full Text] [Related]
14. Characterization and localization of thromboxane A2 receptor in human and guinea-pig nasal mucosa using radiolabelled (+)-S-145.
Arimura A; Miwa M; Hasegawa H; Kishino J; Notoya M; Yasui K; Komori M; Iwata S
Br J Pharmacol; 1998 Jun; 124(4):795-803. PubMed ID: 9690873
[TBL] [Abstract][Full Text] [Related]
15. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.
Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM
Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791
[TBL] [Abstract][Full Text] [Related]
18. 8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro.
Kawikova I; Barnes PJ; Takahashi T; Tadjkarimi S; Yacoub MH; Belvisi MG
Am J Respir Crit Care Med; 1996 Feb; 153(2):590-6. PubMed ID: 8564103
[TBL] [Abstract][Full Text] [Related]
19. Thromboxane A2 (TP) receptor in the non-pregnant porcine myometrium and its role in regulation of spontaneous contractile activity.
Cao J; Wakatsuki A; Yoshida M; Kitazawa T; Taneike T
Eur J Pharmacol; 2004 Feb; 485(1-3):317-27. PubMed ID: 14757156
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the thromboxane (TP-) receptor subtype involved in proliferation in cultured vascular smooth muscle cells of rat.
Ko FN; Yu SM; Kang YF; Teng CM
Br J Pharmacol; 1995 Sep; 116(2):1801-8. PubMed ID: 8528563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
